On May 27, 2020 ESSA Pharma Inc. (Nasdaq: EPIX; TSX-V: EPI; ) ("ESSA" or the "Company"), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer reported the Company will be presenting at the Jefferies Virtual Healthcare Conference on Thursday June 4, 2020 at 3:30pm Eastern (Press release, ESSA, MAY 27, 2020, View Source [SID1234558590]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. David. R. Parkinson, Chief Executive Officer, will provide a corporate overview of the Company’s business and will be available for one-on-one meetings from June 2 – 4, 2020. ESSA’s Chief Operating Officer, Peter Virsik, and Chief Financial Officer, David S. Wood, will also be in attendance.

The presentation will be webcast live and can be accessed through the Investor Relations page at www.essapharma.com. A replay of the presentation will be available on the Company’s website for 90 days.

Presentation Details :

Presentation Date:

Thursday June 4, 2020

Presentation Time:

3:30pm Eastern Time